×

Fresenius CEO on APP Deal

11:10 AM ET Mon, 7 July 2008

Germany's Fresenius plans to buy America's group APP Pharmaceuticals for $3.7 billion. Ulf Schneider, CEO of Fresenius, spoke to CNBC about the proposed $3.7 billion deal.